These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12775623)

  • 1. How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.
    Wager E
    BMJ; 2003 May; 326(7400):1196-8. PubMed ID: 12775623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No more free lunches: how to dance with porcupines.
    Rudolphy S
    BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907495
    [No Abstract]   [Full Text] [Related]  

  • 3. No more free lunches: doctors and journals in the South cut off drug companies at their peril.
    Ana J
    BMJ; 2003 Aug; 327(7410):341-2. PubMed ID: 12907496
    [No Abstract]   [Full Text] [Related]  

  • 4. Doctors and drug companies: the beauty and the beast?
    Guömundsson S
    Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician-industry interactions: there is no such thing as a free lunch.
    Tsai HJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical journals and pharmaceutical companies: uneasy bedfellows.
    Smith R
    BMJ; 2003 May; 326(7400):1202-5. PubMed ID: 12775625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doctors and drug companies.
    Blumenthal D
    N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
    [No Abstract]   [Full Text] [Related]  

  • 8. Doctors, drug companies and medical ethics: a Sri Lankan perspective.
    Malavige GN
    Indian J Med Ethics; 2004; 1(1):26. PubMed ID: 16370067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].
    Lifshitz A; Halabe J; Jasso L; Frati A; Alva C; Arrieta Ó; Burgos R; Campillo C; Celis MÁ; de la Llata M; Domínguez J; Islas R; Moreno M; Plancarte R; Reyes A; Soda A; Verástegui E; Sotelo J
    Gac Med Mex; 2016; 152(3):295-6. PubMed ID: 27335182
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of interest--an ever present challenge.
    Kopp I
    Dtsch Arztebl Int; 2013 Sep; 110(35-36):573-4. PubMed ID: 24078836
    [No Abstract]   [Full Text] [Related]  

  • 11. The speakers' bureau system: a form of peer selling.
    Reid L; Herder M
    Open Med; 2013; 7(2):e31-9. PubMed ID: 24348883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: entanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1189-92. PubMed ID: 12775621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can the relationship between doctors and drug companies ever be a healthy one?
    D'Arcy E; Moynihan R
    PLoS Med; 2009 Jul; 6(7):e1000075. PubMed ID: 19621069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australian regulator insists on greater transparency of industry payments to doctors.
    Coopes A
    BMJ; 2014 Oct; 349():g6335. PubMed ID: 25331811
    [No Abstract]   [Full Text] [Related]  

  • 17. Doctors and pharma in China.
    Lancet; 2013 Jul; 382(9887):102. PubMed ID: 23849911
    [No Abstract]   [Full Text] [Related]  

  • 18. Conflicts of Interest.
    Strandberg TE
    N Engl J Med; 2015 Aug; 373(8):779. PubMed ID: 26287865
    [No Abstract]   [Full Text] [Related]  

  • 19. Conflicts of Interest.
    Fleischman W; Newman DH
    N Engl J Med; 2015 Aug; 373(8):778-9. PubMed ID: 26287864
    [No Abstract]   [Full Text] [Related]  

  • 20. Conflicts of Interest.
    Roper N
    N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.